Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SLC6A1 | P30531 | 4/20 | 0.35 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.35 |
| ▸ | PREP | P48147 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15412932 | 1.00 | ATM (0.36) | ATML3MBTL1LMNASLC6A1SLC6A11 | |
| SCHEMBL15412695 | 1.00 | ATM (0.36) | ATML3MBTL1LMNASLC6A1SLC6A11 | |
| SCHEMBL17923217 | 0.95 | CHRM2 (0.38) | LMNA | |
| SCHEMBL17941193 | 0.95 | CHRM2 (0.38) | LMNA | |
| SCHEMBL17923226 | 0.95 | CHRM2 (0.38) | LMNA | |
| SCHEMBL30899499 | 0.94 | CHRM2 (0.40) | LMNA | |
| SCHEMBL28833909 | 0.90 | KCNA3 (0.34) | LMNA | |
| SCHEMBL20595723 | 0.90 | KCNA3 (0.34) | LMNA | |
| SCHEMBL20595800 | 0.90 | KCNA3 (0.34) | LMNA | |
| SCHEMBL10514209 | 0.83 | ATM (0.36) | ATML3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122031506-A | Chiral control | 波涛生命科学有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-12583883-B2 | Asymmetric auxiliary group | WAVE LIFE SCIENCES LTD. (SG) | 2026-03-24 | — | — | US | disclosed |
| US-20260055133-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS | WAVE LIFE SCIENCES LTD (SG) | 2026-02-26 | — | — | US | disclosed |
| US-12428442-B2 | Compounds, compositions and methods for synthesis | WAVE LIFE SCIENCES LTD. (SG) | 2025-09-30 | — | — | US | disclosed |
| US-20240229026-A1 | CHIRAL CONTROL | WAVE LIFE SCIENCES LTD. (SG) | 2024-07-11 | — | — | US | disclosed |
| US-20240174710-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS | WAVE LIFE SCIENCES LTD. (SG) | 2024-05-30 | — | — | US | disclosed |
| US-11718638-B2 | Compounds, compositions and methods for synthesis | WAVE LIFE SCIENCES LTD. (SG) | 2023-08-08 | — | — | US | disclosed |
| US-11718638-B2 | Compounds, compositions and methods for synthesis | WAVE LIFE SCIENCES LTD. (SG) | 2023-08-08 | — | — | US | disclosed |
| US-11718638-B2 | Compounds, compositions and methods for synthesis | WAVE LIFE SCIENCES LTD. (SG) | 2023-08-08 | — | — | US | disclosed |
| EP-4219516-A2 | CHIRAL CONTROL | Wave Life Sciences Ltd. (SG) | 2023-08-02 | — | — | EP | disclosed |
| WO-2018237194-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS | WAVE LIFE SCIENCES LTD. (SG) | 2018-12-27 | — | — | WO | disclosed |
| US-9982257-B2 | Chiral control | WAVE LIFE SCIENCES LTD. (SG) | 2018-05-29 | — | — | US | disclosed |
| US-9885037-B2 | — | — | 2018-02-06 | — | — | US | disclosed |
| US-20170275621-A1 | CHIRAL CONTROL | WAVE LIFE SCIENCES USA, INC. | 2017-09-28 | — | — | US | disclosed |
| US-9598458-B2 | Asymmetric auxiliary group | WAVE LIFE SCIENCES JAPAN, INC. (JP) | 2017-03-21 | — | — | US | disclosed |
| US-20170029445-A1 | ASYMMETRIC AUXILIARY GROUP | WAVE LIFE SCIENCES JAPAN, INC. (JP) | 2017-02-02 | — | — | US | disclosed |
| US-20150211006-A1 | CHIRAL CONTROL | WAVE LIFE SCIENCES USA, INC. | 2015-07-30 | — | — | US | disclosed |
| US-20150197540-A1 | ASYMMETRIC AUXILIARY GROUP | WAVE LIFE SCIENCES LTD. (SG) | 2015-07-16 | — | — | US | disclosed |
| EP-2872147-A2 | CHIRAL CONTROL | Wave Life Sciences Pte. Ltd. (SG) | 2015-05-20 | — | — | EP | disclosed |
| WO-2014012081-A2 | CHIRAL CONTROL | ONTORII, INC. (US) | 2014-01-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718638-B2 | Compounds, compositions and methods for synthesis | ALKBH1, DUT, RNGTT | ATM 4229/4885L3MBTL1 1497/4885LMNA 434/4885 |
| US-20150197540-A1 | ASYMMETRIC AUXILIARY GROUP | NIT2, IDH1, HBG2 | ATM 2411/4885L3MBTL1 3487/4885LMNA 3240/4885 |
| US-20170275621-A1 | CHIRAL CONTROL | RNGTT, POLI, NSUN3 | ATM 4785/4885L3MBTL1 420/4885LMNA 1868/4885 |
| US-20240229026-A1 | CHIRAL CONTROL | RNGTT, POLI, NSUN3 | ATM 4785/4885L3MBTL1 420/4885LMNA 1868/4885 |
| US-12583883-B2 | Asymmetric auxiliary group | AGL, RNMT, NSUN2 | ATM 3331/4885L3MBTL1 1449/4885LMNA 1824/4885 |
| US-20170029445-A1 | ASYMMETRIC AUXILIARY GROUP | NIT2, IDH1, HBG2 | ATM 2411/4885L3MBTL1 3487/4885LMNA 3240/4885 |
| US-12428442-B2 | Compounds, compositions and methods for synthesis | ALKBH1, DUT, RNGTT | ATM 4229/4885L3MBTL1 1497/4885LMNA 434/4885 |
| US-20260055133-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS | NSUN2, NSUN3, NOP2 | ATM 4625/4885L3MBTL1 600/4885LMNA 284/4885 |
| US-20150211006-A1 | CHIRAL CONTROL | RNGTT, POLI, NSUN3 | ATM 4785/4885L3MBTL1 420/4885LMNA 1868/4885 |
| US-20240174710-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS | ALKBH1, DUT, RNGTT | ATM 4229/4885L3MBTL1 1497/4885LMNA 434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.